FDA Approved: PAMELOR — Supplemental Application (SpecGx LLC)

View source ↗

Summary

FDA approved a supplemental application for PAMELOR (nortriptyline hydrochloride) submitted by SpecGx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• PAMELOR (Nortriptyline hydrochloride)

Snippet

SUPPL AP for PAMELOR (NORTRIPTYLINE HYDROCHLORIDE)